Article: PDF OnlyThe role of chemotherapy in refractory prostate cancerJones, William G.Author Information University Department of Radiotherapy, Cookridge Hospital, Leeds, UK William G. Jones, University Department of Radiotherapy, Tunbridge Building, Cookridge Hospital, Hospital Lane, Leeds LS16 6QB, UK. Current Opinion in Urology: October 1991 - Volume 1 - Issue 1 - p 21-24 Buy Abstract Chemotherapy has at present no part in the standard management of hormone-resistant prostate cancer because of disappointing results of clinical studies. The definition of objective response is difficult in this ‘end-stage’ patient population. The search for active drugs continues, including the use of animal models and in vitro techniques. © Lippincott-Raven Publishers.
